PRMT5 and rheumatoid arthritis: Although lower than in SSc, anti-PRMT5 antibodies levels in patients with RA (median = 0.104, range 0.054–0.261) were also significantly elevated compared to healthy controls (p < 0.001, Fig. 1A).